Abstract

Chemical screening of large populations has serious limitations that are related to statistical properties of such groups and to commonly used methods. Among the pitfalls are low disease prevalence, extrapolating research data to screening practice, laboratory variation, ill-defined limits, unselected specimens, and screening for unbeatable diseases. Unless these limitations are understood, screening can be useless and costly.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.